Real-World Patterns of First-Line Hydroxyurea Treatment Among Patients with Essential Thrombocythemia in US Community Oncology Practices

被引：0
|
作者：
Yu, Jingbo
Colucci, Philomena
Paranagama, Dilan Chamikara
Sivaraman, Smitha
Atanasov, Pavel
Hanna, Becky
Tang, Jackson
Parasuraman, Shreekant V.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4203
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World First-Line Treatment Patterns Among US Carcinoid Syndrome Patients
    Sun, Gordon H.
    Neary, Maureen P.
    Chang, Eunice
    Broder, Michael S.
    PANCREAS, 2015, 44 (02) : 359 - 360
  • [2] Real-world patient characteristics and treatment patterns of ruxolitinib among patients with advanced essential thrombocythemia at community clinical practice
    Verstovsek, Srdan
    Amoloja, Theresa
    Scherber, Robyn M.
    Yu, Jingbo
    LEUKEMIA RESEARCH, 2021, 110
  • [3] Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naive essential thrombocythemia patients in a real-world setting
    Ito, Tomoki
    Hashimoto, Yoshinori
    Tanaka, Yasuhiro
    Nakaya, Aya
    Fujita, Shinya
    Satake, Atsushi
    Nakanishi, Takahisa
    Konishi, Akiko
    Hotta, Masaaki
    Yoshimura, Hideaki
    Ishii, Kazuyoshi
    Hashimoto, Akiko
    Kondo, Toshinori
    Omura, Hiromi
    Shinzato, Isaku
    Tanaka, Takayuki
    Nomura, Shosaku
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (02) : 116 - 123
  • [4] First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting
    Dennen, Syvart
    Harton, Joanna
    Cockrum, Paul
    Kim, George P.
    MacEwan, Joanna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Real-World Treatment Patterns and Healthcare Costs Among Patients with FL with Early Treatment Failure of First-Line Chemoimmunotherapy
    Leslie, Lori A.
    Emond, Bruno
    Lafeuille, Marie-Helene
    Vermette-Laforme, Maude
    Lefebvre, Patrick
    Huang, Qing
    AMERICAN HEALTH AND DRUG BENEFITS, 2022, 15 (03): : 75 - 85
  • [6] FIRST-LINE MAINTENANCE AMONG ADVANCED OVARIAN CANCER PATIENTS IN THE US ONCOLOGY NETWORK: A REAL-WORLD RETROSPECTIVE COHORT STUDY
    Chase, Dana
    Liu, Jinan
    Moore-Schiltz, Laura
    Perhanidis, Jennifer
    Bulsara, Purva
    Patton, Gregory
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A33 - A33
  • [7] How do real-world treatment patterns compare to guideline recommendations for first-line metastatic breast cancer patients in US community clinics?
    Chu, L.
    Yoo, B.
    Carrigan, G.
    Lai, C.
    Beattie, M.
    Reyes, C.
    CANCER RESEARCH, 2017, 77
  • [8] First-Line Pembrolizumab-Combination Therapy for Advanced Squamous NSCLC: Real-World Outcomes at US Oncology Practices
    Liu, S.
    Rai, P.
    Wang, D.
    Hu, X.
    Schwarzenberger, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S383 - S384
  • [9] Real-world treatment patterns and clinical outcomes with palbociclib combination therapy received in US community oncology practices
    Trocio, J.
    Lin, J.
    Fisher, M. D.
    Hu, N.
    Davis, C.
    Mcroy, L.
    Walker, M. S.
    Iyer, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Real-world treatment patterns and outcomes among patients with BRAF plus metastatic melanoma refractory to first-line immunotherapy
    Truong, T. G.
    Chandra, S.
    Connolly, L.
    Shah, R.
    Byrne, C.
    Tang, J.
    Eroglu, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S673 - S673
12345